A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...

Researchers tracking nearly 1,000 individuals with post-COVID-19 syndrome observed minimal changes in their symptoms during ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

A simple blood test might determine which patients are at risk for long COVID, a new study says.Higher levels of le ...

Leukocyte count, a widely available and inexpensive clinical marker of inflammation, may help predict the severity of long COVID symptoms in postmenopausal women, researchers reported.

A new study comparing blood samples from menopausal women pre- and post-COVID shows that those with elevated leukocyte (white ...

“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...

Tamara Dörr, M.D., from the Cantonal Hospital St. Gallen in Switzerland, and colleagues assessed the burden and course of PASC in health care workers during a 30-month period. The analysis included ...

A spike in flu cases in NY offered clues on when the season may end, underscoring it's not too late to get a flu shot.

Women are more likely than men to develop long COVID, a new study finds, with the highest risk in women ages 40 to 54. Women ...

It’s been almost four years since the U.S. Food and Drug Administration approved the first Covid-19 vaccine. Emphasis has been given to get the jab as it can help to protect you against developing ...